CORPORATE - 19-01-2016

Kedrion Biopharma Expands Immunoglobulin Therapies Portfolio

Gains Commercial Rights in the U.S. to BIVIGAM®, a Recently Approved IGIV Brand

read more 

CORPORATE - 20-07-2015

KEDPlasma welcomes donors to its new Augsburg collection center

Plasma collected in Germany is essential to Kedrion Biopharma’s European plasma-derived therapies

read more 

CORPORATE - 29-06-2015

Humanitarian programme augments access to clotting factors in developing countries

Kedrion helps the WISH project come true: Italian CNS[NM1] and the World Federation of Hemophilia sign agreement in London

read more 

CORPORATE - 19-02-2015

Kedrion employees in the US volunteer to help others

Leaving every place we visit a little better than when we arrived: this is Kedrion Cares

read more 

Pages